72 results
Page 3 of 4
10-Q
9gip7tu
14 May 21
Quarterly report
4:31pm
10-K
EX-10.9
otzmkq
31 Mar 21
Annual report
4:30pm
10-K
2nvqfeh
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
n2tnbjyq7w42v99rga1
31 Mar 21
Annual report
4:30pm
10-K
EX-10.3
8y1k94wq
31 Mar 21
Annual report
4:30pm
10-K
EX-10.4
ghf2ob09 49yvvp03ur
31 Mar 21
Annual report
4:30pm
10-K
EX-10.2
lyg 15iw3y
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
h0t5j4wr8
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
EX-4.4
jvpen0dfeqo
29 Jan 21
Shelf registration
4:48pm
S-3
wxz4k9i v0f3q
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
ld5ktut6djs5oek3z0tg
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
u8h6qtvq2f 3wx
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.2
xxqls50
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-10.1
w00 msd3bzmohb5miv
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
45tup8hk4 ynmhsh
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.1
fqo3mlr1lkwtygjgrhd
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
il2qi p8uneaubcr
2 Nov 20
Prospectus supplement
12:00am